๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mo1918 Sirolimus use is Associated With Increased Risk for Cardiovascular Events Following Liver Transplantation

โœ Scribed by Doycheva, Iliana; Couto, Claudia A.; Gelape, Claudio L.; Kish, Jonathan; Levi, David; Martin, Paul; Levy, Cynthia


Book ID
122287118
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
110 KB
Volume
142
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Sirolimus-based immunosuppression is ass
โœ Christian Toso; Shaheed Merani; David L. Bigam; A.M. James Shapiro; Norman M. Kn ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 207 KB ๐Ÿ‘ 1 views

Liver transplantation is an important treatment option for selected patients with nonresectable hepatocellular carcinoma (HCC). Several reports have suggested a lower risk of posttransplant tumor recurrence with the use of sirolimus and a higher one with calcineurin inhibitors, but the selection of